StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
058630.KQ$4320.00-3.68%
Fair $4320.00+0.0%

058630.KQ

Mgame Corp.

Unknown / UnknownKOSDAQ

$4320.00

-165.00 (-3.68%)

Fairly Valued+0.0%Fair Value $4320.00Fund rank 33/100 · Data gapFallback financials|
SA 44/C
F-Score: 6/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 25% · confianza 25%

FCF escenarios

weak_data · normalized FCF $5.6B · quality 59.3/100

Data gap 33/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 52/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

44/100

C

Piotroski

6/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · 058630.KQLocal privado en este navegador · Mgame Corp.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$80.4B

P/E

5.0x

↓

EV/EBITDA

1.7x

↓

ROE

11.7%

↑

Gross Margin

95.1%

↑

Debt/Equity

0.01

↓
52-Week Range$4320
$4170$7660

TradingView lightweight chart

058630.KQ price, volumen y niveles de valoración

Último $4,320Periodo -69.7%
Fair value: $4,320

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+7.6%

FCF CAGR

-59.5%

FCF margin

2.6%

FCF / Net income

0.15x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $91.74B · net income $16.03B · FCF $2.36B

2022-FY → 2025-FY

Gross margin

95.1%-4.4% pts

Operating margin

19.1%-21.8% pts

Net margin

17.5%-13.3% pts

FCF margin

2.6%-45.8% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$91.74B$91.74B$83.42B$81.63B$73.65B
Net Income$16.03B$16.03B$15.67B$21.86B$22.65B
EBITDA$26.25B$26.25B$25.54B$26.86B$30.32B
EPS861.00861.00828.001144.001162.00
Gross Margin95.1%95.1%94.9%96.2%99.5%
Operating Margin19.1%19.1%15.4%26.1%40.9%
Net Margin17.5%17.5%18.8%26.8%30.8%
Balance Sheet
Debt/Equity0.010.010.010.010.00
Cash Flow
Free Cash Flow$2.36B$2.36B$5.57B$24.29B$35.65B
Returns
ROE11.7%11.7%12.6%19.2%24.3%
Valuation
P/E5.025.026.515.256.67
EV/EBITDA1.701.701.472.653.63
P/B0.590.590.821.011.62
Growth & Yield
Revenue Growth10.0%10.0%2.2%10.8%—
EPS Growth4.0%4.0%-27.6%-1.5%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

-23.6%

fácil

EPS terminal req.

$383.33

Spread vs growth

27.6%

5Y implied EPS CAGR

-11.6%

fácil

EPS terminal req.

$463.83

Spread vs growth

15.6%

10Y implied EPS CAGR

-1.4%

fácil

EPS terminal req.

$747.00

Spread vs growth

5.4%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -15.1%

Total return

-15.1%

Start / end P/E

6.1x → 5.0x

EPS bridge

828.00 → 861.00

Residual

-0.7%

EPS growth+4.0%
Multiple rerating-18.4%
Dividend+0.0%
Residual / FX / buybacks / cross-term-0.7%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.